Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

39.320
+0.8202.13%
Volume:3.81M
Turnover:149.44M
Market Cap:238.08B
PE:48.71
High:40.000
Open:38.360
Low:37.960
Close:38.500
52wk High:40.000
52wk Low:15.783
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.51
T/O Rate:0.06%
Dividend:0.37
Dividend Rate:0.95%
EPS(LYR):0.807
ROE:16.21%
ROA:8.35%
PB:6.99
PE(LYR):48.71
PS:16.49

Loading ...

Hansoh Pharmaceutical Group Stock Climbs 4.8% in Hong Kong

Dow Jones
·
Yesterday

Hansoh Pharmaceutical Group Stock Advances 1.8% in Hong Kong

Dow Jones
·
Nov 10

Hansoh Pharma Reports Positive Phase 2 Results for HS-20089 in Platinum-Resistant Ovarian Cancer

Reuters
·
Nov 10

Zhongtai International: Breakthroughs in Overseas Expansion of Innovative Drugs, Rational Drug Pricing Policies Expected; Key Recommendations Include HANSOH PHARMA (03692) and INNOVENT BIO (01801)

Stock News
·
Nov 06

Hansoh Pharmaceutical Group Stock Climbs 1.0% in Hong Kong

Dow Jones
·
Nov 05

Hansoh Pharmaceutical (03692) Releases October Monthly Return with Steady Issued Shares

Bulletin Express
·
Nov 03

Does Regulatory Progress for RET Inhibitor Reshape the Oncology Pipeline Momentum at Hansoh (SEHK:3692)?

Simply Wall St.
·
Nov 03

Market Strength Still Relies on Tech Leadership

Stock News
·
Nov 03

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Stock News
·
Nov 02

Hansoh Pharmaceutical Group (SEHK:3692) Valuation in Focus After Regulatory Progress on Novel RET Inhibitor

Simply Wall St.
·
Nov 01

Hansoh Pharmaceutical Group Stock Climbs 4.2% in Hong Kong

Dow Jones
·
Oct 31

Hansoh Pharmaceutical Group Stock Advances 1.2% in Hong Kong

Dow Jones
·
Oct 24

Hansoh Pharma Gets China Acceptance for Lung Cancer Drug Application

MT Newswires Live
·
Oct 23

Hansoh (3692) Announces NDA Acceptance for HS-10365 Capsules by NMPA

Bulletin Express
·
Oct 23

China NMPA Accepts Hansoh Pharma's NDA for HS-10365 in RET Fusion-Positive NSCLC

Reuters
·
Oct 23

Hansoh Pharmaceutical - China's Nmpa Accepts Nda for Hansoh's Hs-10365 Capsules

THOMSON REUTERS
·
Oct 23

Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong

Dow Jones
·
Oct 23

Hansoh Pharmaceutical Group Stock Slides 1.4% in Hong Kong

Dow Jones
·
Oct 21

Roche Partnership Could Be a Game Changer for Hansoh Pharmaceutical Group (SEHK:3692)

Simply Wall St.
·
Oct 21

Hansoh Pharma's Roche Deal Could Help Unlock Commercial Potential -- Market Talk

Dow Jones
·
Oct 20